During the first phase of HCC, the DeepTrace method exhibited a sensitivity of 89.6 and 89.5%, exceeding the sensitivity of Alpha Fetoprotein (AFP) which showed much worse performance (Deng et al., 2023). The gene discussed is AFP; the disease is hepatocellular carcinoma.